Mark Wheeldon, speaks at DIA Annual Conference 2011
Formedix CEO, Mark Wheeldon met with PharmaVoice Editor, Taren Grom at the 47th DIA Annual Meeting in Chicago, June 19-23, 2011.
Mark discussed how Origin Enterprise, the newly released version of Formedix flagship software, Origin Study Modeller, builds upon the stand-alone version to save time and money in clinical trials. He also shared his experiences on the importance of integrating Clinical Data Interchange Standards Consortium (CDISC) into the drug development process.